Monotherapy IVIG Gamunex-C for HMG-CoA Reductase Auto-Antibody Positive Necrotizing Myopathy Treatment (The MIGHT Trial)
Stopped No Participants Enrolled
Conditions
- Immune-Mediated Necrotizing Myopathy
Interventions
- DRUG: Gamunex-C
- DRUG: Albumin
Sponsor
University of Washington
Collaborators